A Workaround For Tiny Smartwatch Screens And Fat Fingers

Carnegie Mellon scientists have developed an interface that works through twists and tilts as well as clicks.

What's the Latest Development?

Presented at this month's ACM CHI Conference on Human Factors in Computing Systems was a prototype of a smartwatch that worked by tilting, twisting, and clicking the screen body instead of tapping or sliding atop its face. In a video created for the device, the team of Carnegie Mellon developers demonstrated several sample applications, including a music application that can scroll through songs, select a song, and change the volume, all through actions that don't require the user to touch the screen.

What's the Big Idea?

Currently, smartwatch technology requires small screens and mostly finger-based interaction, which makes them challenging to use for more than a few people. According to team member and Carnegie Mellon assistant professor Chris Harrison, they sought to avoid that cramped feeling when building the prototype. The result is definitely bigger than the typical smartwatch, which could bring with it other problems, such as battery strain. However, Harrison hints that the team's next project might involve an interface that doesn't require touching the smartwatch at all.

Photo Credit: Chris Harrison

Read it at MIT Technology Review

Compelling speakers do these 4 things every single time

The ability to speak clearly, succinctly, and powerfully is easier than you think

Former U.S. President Barack Obama speaks during a Democratic Congressional Campaign Committee rally at the Anaheim Convention Center on September 8, 2018 in Anaheim, California. (Photo by Barbara Davidson/Getty Images)
Personal Growth

The ability to communicate effectively can make or break a person's assessment of your intelligence, competence, and authenticity.

Keep reading Show less

Antimicrobial resistance is a growing threat to good health and well-being

Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.

Image courtesy of Pfizer.
  • Antimicrobial-resistant pathogens are one of the largest threats to global health today.
  • As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
  • If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
  • Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
  • By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
Keep reading Show less

Preserving truth: How to confront and correct fake news

Journalism got a big wake up call in 2016. Can we be optimistic about the future of media?

  • "[T]o have a democracy that thrives and actually that manages to stay alive at all, you need regular citizens being able to get good, solid information," says Craig Newmark.
  • The only constructive way to deal with fake news? Support trustworthy media. In 2018, Newmark was announced as a major donor of two new media organizations, The City, which will report on New York City-area stories which may have otherwise gone unreported, and The Markup, which will report on technology.
  • Greater transparency of fact-checking within media organizations could help confront and correct fake news. Organizations already exist to make media more trustworthy — are we using them? There's The Trust Project, International Fact-Checkers Network, and Tech & Check.
Keep reading Show less